Richard Clark (pharmacologist): Encyclopedia with 57,945 entries from biotech, medicine & life sciences.

Richard Clark (pharmacologist)

For people of the same name, please see Richard Clark.

As of May 5th, 2005, Richard T. Clark is the CEO and president of Merck Pharmaceutical Company. From 2003 until May 2005, he was the head of the Merck Manufacturing Division (MMD).

Born in 1946, graduated from Washington & Jefferson College (1968), MBA from American University (1970), Lieutenant in US Army (1970-1972) employed by Merck since 1972.

v • d • e Merck & Co., Inc.
Corporate Directors:	Richard Clark · Johnnetta Cole · William Harrison · William Kelley · Rochelle Lazarus · Thomas Shenk · Anne Tatlock · Samuel Thier · Wendell Weeks · Peter Wendell
Products:	Indinavir · Aprepitant · Alendronate · Rizatriptan · Finasteride · Losartan · Lovastatin · Montelukast · Rofecoxib · Ezetimibe/simvastatin · Ezetimibe · Raltegravir · Simvastatin · Sitagliptin · Vorinostat · The Merck Index · The Merck Manual
Annual Revenue: $22.9 billion USD (2% FY 2004) · Employees: 63,000 · Stock Symbol: NYSE: MRK · Website: www.merck.com

Categories: American pharmacologists | Merck

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Richard_Clark_(pharmacologist)". A list of authors is available in Wikipedia.

Life Science Encyclopedia